79 Biotech VC Firms

Pre-seed firm guaranteeing funds in 10 business days.

Learn which startups 3CC | Third Culture Capital invests in, what size check sizes they write, and who their partners are (e.g. Julien Pham).

Early-stage life sciences with 4:59 Initiative model.

Acts as VC and venture studio co-founding startups with 25-30% capital allocation.

Led by active AI practitioners Socher, Manning, Goldbloom.

Invests at concept stage, co-founding breakthrough life sciences platforms.

AbbVie Ventures is the strategic venture capital arm of AbbVie, investing mainly at Seed and Series A in discovery and preclinical therapeutics companies aligned with AbbVie's R&D areas.

Learn which startups Acequia Capital (AceCap) invests in, what size check sizes they write, and who their partners are (e.g. Hank Vigil).

Climate-focused agrifood fund with rare food-policy expertise

Learn which startups AgFunder invests in, what size check sizes they write, and who their partners are (e.g. Michael Dean).

Focuses exclusively on AI-first companies in technical domains.

Alexandria Venture Investments is the strategic venture arm of life science REIT Alexandria Real Estate Equities, backing seed, early and growth-stage biotech, agrifoodtech and climate companies since 1996.

Amgen Ventures is the strategic venture arm of Amgen, investing since 2004 in private biotechnology companies and venture funds aligned with Amgen's research priorities in oncology, inflammation and other areas.

Leads mega-rounds for frontier-tech visions with 150+ platform team and media operations.

Dedicated bio and health fund within a16z, investing in founders applying engineering and computational approaches to biology and healthcare.

Angelini Ventures is the Rome-based venture capital firm of Angelini Industries, investing a €300 million commitment in biotech and healthtech companies across Europe and North America.

Applied Ventures is the Santa Clara venture capital arm of Applied Materials, a stage-agnostic deep tech investor in semiconductors, photonics, AI hardware, advanced materials and robotics startups.

Learn which startups Artis Ventures (AV) invests in, what size check sizes they write, and who their partners are (e.g. Stuart Peterson).

Seed and early-stage investor emphasizing biotech company creation.

Deliberate 60/40 tech/healthcare split with transparent partner scoring.

Learn which startups Carbon Silicon Ventures invests in, what size check sizes they write, and who their partners are (e.g. Nish Bhat).

Learn which startups Civilization Ventures invests in, what size check sizes they write, and who their partners are (e.g. Shahram Seyedin-Noor).

Contrarian n-of-1 investor across frontier sectors.

Venture firm powered by a network of top university students and recent graduates, scouting and investing in the next generation of founders.

Analytics-driven co-investor making rapid decisions using proprietary model.

Learn which startups Cultivian Sandbox Ventures invests in, what size check sizes they write, and who their partners are (e.g. Steve Engelberg).

Targets companies applying modern computation to agriculture, mining, and health.

Learn which startups Decheng Capital invests in, what size check sizes they write, and who their partners are (e.g. ).

Learn which startups Dolby Family Ventures invests in, what size check sizes they write, and who their partners are (e.g. Pascal Levensohn).

Learn which startups E1 Ventures invests in, what size check sizes they write, and who their partners are (e.g. ).

E2MC Ventures is a Los Angeles-based early-stage venture firm specializing in the space economy, investing in satellite technology, launch services, in-space manufacturing, and the broader ecosystem of technologies enabling a multi-planetary future. The firm focuses on pre-seed and seed stage companies where its deep aerospace network and technical expertise provide the most leverage. E2MC backs founders building infrastructure for the commercial space industry and adjacent deep tech sectors.

Fidelity-backed formation engine for gene therapy and rare diseases.

Learn which startups FPV Ventures invests in, what size check sizes they write, and who their partners are (e.g. Pegah Ebrahimi).

Learn which startups FemHealth Ventures invests in, what size check sizes they write, and who their partners are (e.g. ).

Operator-heavy team backing pre-product deep-tech moonshots.

Learn which startups Flagship Pioneering invests in, what size check sizes they write, and who their partners are (e.g. Noubar Afeyan).

Learn which startups Flare Capital Partners invests in, what size check sizes they write, and who their partners are (e.g. Bill Geary).

Contrarian, founder-maximalist VC backing hard scientific breakthroughs.

Learn which startups FundersClub invests in, what size check sizes they write, and who their partners are (e.g. ).

Invests in purpose-driven entrepreneurs reinventing industries.

Google's financially-driven VC with design studio and ML scoring.

Learn which startups Genoa Ventures invests in, what size check sizes they write, and who their partners are (e.g. ).

Learn which startups Hatteras Venture Partners invests in, what size check sizes they write, and who their partners are (e.g. ).

Founded by Eric Schmidt; invests in sensors, ML, and robotics.

Deeptech seed fund investing across chips, chemicals, energy, robotics.

Kaiser Permanente Ventures is the strategic venture arm of Kaiser Permanente, investing in healthcare IT, care delivery services, diagnostics and therapeutics companies that address needs in healthcare delivery.

KittyHawk Ventures is a New York-based venture firm that invests across the capital stack, from frontier seed rounds all the way through pre-IPO growth equity, focusing on transformative technology companies in sectors including fintech, enterprise software, and aerospace. The firm takes a flexible, stage-agnostic approach that allows it to build concentrated positions in breakout companies over multiple rounds. KittyHawk is known for its long-term partnership model and willingness to back unconventional founders with bold visions.

LG Technology Ventures is the Santa Clara venture arm of South Korea's LG Group, backing early and growth-stage companies in AI, batteries and energy, life sciences, materials and enterprise software.

Leaps by Bayer is the strategic investment unit of Bayer AG, backing and forming companies that pursue fundamental breakthroughs in health and agriculture across ten defined challenges.

Lilly Ventures is Eli Lilly's global investment arm, formed in 2001, investing in early-stage biotech and novel science as one pillar of the Lilly Catalyze360 program for young drug developers.

Deep technology venture firm investing in emerging science and technology ventures in energy, healthcare, and defense.

Evergreen fund integrated with $10B+ hedge-fund platform.

Serial founder-led with Signal platform and CEO Guild network.

The Novartis Venture Fund is the corporate venture arm of Novartis, investing USD 5 to 10 million at seed and Series A in therapeutics companies across North America and Europe.

Healthcare-only platform spanning seed through IPO via public/private arms.

Pfizer Ventures is the venture capital arm of Pfizer, investing in biotech companies in oncology, inflammation and immunology, cardiometabolic disease, vaccines and next-generation modalities.

Boston seed investor supporting professional growth.

Deep technology venture fund investing in AI, robotics, and synthetic biology startups with transformative potential.

Polaris Partners is a Boston venture capital firm founded in 1996 that invests mainly in biotechnology and healthcare companies, from company creation through later rounds. It has more than $5 billion in committed capital and runs two affiliated vehicles: the Polaris Innovation Fund for academic research and the Polaris Growth Fund for profitable, founder-owned software companies.

Deep tech venture firm investing in breakthrough scientific startups across energy, transportation, infrastructure, and health.

Invests in very-early to early-stage AI startups with AI research ties.

Solo GP leveraging Google/Netflix/LinkedIn experience to back hard-tech.

S32, originally named Section 32, is a Palo Alto venture capital firm founded by Bill Maris, who started GV (Google Ventures) and ran it as CEO. S32 invests mainly at Series A and Series B in AI, computational biology, infrastructure, cybersecurity and enterprise software, manages more than $3 billion, and held a $413.5 million first close on its sixth fund in September 2025.

Sanofi Ventures is the corporate venture arm of Sanofi, investing from seed to crossover in biotech and AI and digital health companies from an evergreen fund of more than $1.4 billion.

Takeda Ventures, Inc. is the corporate investment arm of Takeda Pharmaceutical, holding venture stakes in therapeutics companies in oncology, cell therapy, immunology and genetic medicine.

MIT-linked venture firm investing in tough tech companies solving the world's biggest problems across energy, health, and computing.

Drug-discovery company creator incubating orphan and rare disease treatments.

Focuses on enabling infrastructure for the space economy.

UPMC Enterprises is the innovation, commercialization and venture capital arm of Pittsburgh health system UPMC, investing in and building digital health and life sciences companies from early to growth stage.

Venture capital firm with roots in the Rockefeller family, investing in technology and healthcare companies for over 50 years.

Healthcare-focused venture arm of Venrock, the Rockefeller family venture fund, investing in biotech and digital health.

Creates companies from in-house discovery labs with big-pharma discipline.

Venture capital firm investing in agtech, food tech, and biotechnology companies that address global food security and sustainability challenges. They focus on technologies that improve agricultural productivity and food system resilience.

JJDC is the venture capital arm of Johnson & Johnson, investing in breakthrough healthcare innovations across pharmaceuticals, medical devices, and consumer health. They focus on companies developing transformative solutions for patients worldwide.

Main Sequence Ventures is a deep tech venture capital firm spun out of CSIRO, Australia's national science agency. The firm invests in startups built on breakthrough science and technology, bridging the gap between research and commercialization.

Life sciences venture capital firm investing in biotechnology, pharmaceutical, and medical technology companies. Focuses on translating breakthrough scientific discoveries into transformational medicines and healthcare solutions.

A clinical-stage biopharma company that discovers and develops medicines for devastating diseases. Operates a unique model combining venture creation with drug development.

Roche's strategic investment arm focused on early-stage companies developing breakthrough healthcare technologies. Invests in innovative therapeutics, diagnostics, and digital health solutions that align with Roche's strategic priorities.

Thrive Capital is a New York venture capital firm founded by Joshua Kushner in 2009. It invests from seed through late-stage growth rounds, mostly in software, AI, fintech and frontier technology. In February 2026 it closed Thrive X at more than $10 billion, split into $1 billion for early-stage investments and $9 billion for growth-stage investments.